Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Zlabinger

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Clinical Transplantation|April 1, 1994
Circulating serum levels of soluble CD23 (sCD23) after renal transplantationO Traindl, C Gisinger, S Reading, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitroG A Böhmig, J Kovarik, W Holter, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 1, 1988
ATG overdose in a kidney-grafted patient. Clinical course and possible implicationsG J Zlabinger, E Pohanka, W Doleschel, et al.
Transplantation Proceedings|August 1, 1990
Immunologic monitoring in OKT3-treated kidney graft recipientsG J Zlabinger, D Maurer, W Ulrich, et al.
Transplantation Proceedings|February 1, 1989
Determination of serum OKT3 levels with flow cytometryG J Zlabinger, W Ulrich, A Sonnleitner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Induction of alloantigen-specific hyporesponsiveness in vitro by n-butyrate: antagonistic effect of cyclosporin AG A Böhmig, T Wekerle, M D Säemann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Insensitivity to cyclosporine may explain the HLA-DRw6 recipient effectS Kudlacek, G J Zlabinger, E Pohanka, et al.
The American Journal of Medicine|February 1, 1988
Anti-thymocyte globulin overdosage--risk or potential benefit?G J Zlabinger, E Pohanka, W Doleschel, et al.
Transplantation Proceedings|August 15, 2002
CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibitedM D Säemann, P Kelemen, M Zeyda, et al.
Transplantation|May 27, 1995
Induction of alloantigen-specific hyporesponsiveness in vitro by the short-chain fatty acid N-butyrateG A Böhmig, B Csmarits, A Cerwenka, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Clinical Transplantation|April 1, 1994
Circulating serum levels of soluble CD23 (sCD23) after renal transplantationO Traindl, C Gisinger, S Reading, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitroG A Böhmig, J Kovarik, W Holter, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 1, 1988
ATG overdose in a kidney-grafted patient. Clinical course and possible implicationsG J Zlabinger, E Pohanka, W Doleschel, et al.
Transplantation Proceedings|August 1, 1990
Immunologic monitoring in OKT3-treated kidney graft recipientsG J Zlabinger, D Maurer, W Ulrich, et al.
Transplantation Proceedings|February 1, 1989
Determination of serum OKT3 levels with flow cytometryG J Zlabinger, W Ulrich, A Sonnleitner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996
Induction of alloantigen-specific hyporesponsiveness in vitro by n-butyrate: antagonistic effect of cyclosporin AG A Böhmig, T Wekerle, M D Säemann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Insensitivity to cyclosporine may explain the HLA-DRw6 recipient effectS Kudlacek, G J Zlabinger, E Pohanka, et al.
The American Journal of Medicine|February 1, 1988
Anti-thymocyte globulin overdosage--risk or potential benefit?G J Zlabinger, E Pohanka, W Doleschel, et al.
Transplantation Proceedings|August 15, 2002
CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibitedM D Säemann, P Kelemen, M Zeyda, et al.
Transplantation|May 27, 1995
Induction of alloantigen-specific hyporesponsiveness in vitro by the short-chain fatty acid N-butyrateG A Böhmig, B Csmarits, A Cerwenka, et al.
Pageof 7